AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

OMDA · NASDAQ · Medical - Healthcare Information Services

Omada Health (OMDA)

Runs between-visit care for cardiometabolic, MSK, GLP-1, and behavioral-health needs.

$20.74

vs last close−0.63 (−2.95%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Mar 2026	Q2 FY26Jun 2026
Revenue	33	33	35	41	46	48	55	61	68	76	78	88
Cost of revenue	13	12	18	17	17	16	23	21	23	22	29	24
Gross profit	20	20	17	25	28	32	32	40	45	54	49	64
	34	33	35	35	37	39	40	45	48	50	53	60
Research & development	8	8	9	9	9	9	9	10	10	12	1	15
	26	25	26	26	28	30	31	35	37	39	3	46
Selling & marketing	0	0	17	0	0	0	20	22	23	25	1	30
General & administrative	0	0	9	0	0	0	11	12	14	14	2	16
Other expenses	0	0	0	0	0	0	0	0	0	0	49	0
Operating income	−14	−13	−18	−10	−9	−7	−8	−4	−3	3	−5	4
	0	−1	−1	−1	−1	−1	−1	−1	−1	2	2	2
Interest income	1	1	1	0	0	0	1	1	2	2	2	2
Interest expense	1	1	1	1	1	1	1	1	0	0	0	0
Other non-operating income	−1	−1	0	0	0	0	0	0	1	−2	−2	−2
Income before tax	−14	−14	−19	−11	−9	−8	−9	−5	−3	5	−3	5
Net income from continuing operations	−14	−14	−19	−11	−9	−8	−9	−5	−3	5	−3	5
Net income	−14	−14	−19	−11	−9	−8	−9	−5	−3	5	−3	5
EPS, basic	−$0.25	−$0.25	−$0.34	−$0.19	−$0.17	−$0.15	−$0.17	−$0.09	−$0.06	$0.09	−$0.05	$0.09
EPS, diluted	−$0.25	−$0.25	−$0.34	−$0.19	−$0.17	−$0.15	−$0.17	−$0.09	−$0.05	$0.09	−$0.05	$0.08
Weighted average shares, basic	56	56	56	56	56	56	56	57	53	58	59	60
Weighted average shares, diluted	56	56	56	56	56	56	56	57	58	58	59	64
EBITDA	−12	−12	−17	−8	−7	−6	−7	−3	−2	7	−1	8
Depreciation & amortization	1	1	1	1	1	1	1	1	1	1	2	3
EBIT	−13	−13	−18	−10	−8	−7	−8	−4	−3	5	−3	5